Delivery Order SPE2DB22D2006-SPE2DB25FW3TA
- Not listed
- The Defense Logistics Agency awarded a $5,608.29 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.98 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on July 22, 2025, with a ceiling value of $3,018.90 and an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is a...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 40 mg tablets (quantity 30) valued at $3,000.96. This competitive award, with no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed-price contract valued at $4,706.88. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCZ 80-25 mg tablets (unit dose, 30-count packages) valued at $3,031.71. This non-set-aside, competitively awarded delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,270.22 and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3TADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units. This contract, valued at $6,670.08, represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Telmisartan delivery order represents a routine execution under this expansive pharmaceutical supply vehicle, consistent with AmerisourceBergen's extensive portfolio of federal medical product deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/20/25 |